825 related articles for article (PubMed ID: 19196529)
1. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
Garcia JM; Polvino WJ
Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
[TBL] [Abstract][Full Text] [Related]
2. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers.
Garcia JM; Polvino WJ
Oncologist; 2007 May; 12(5):594-600. PubMed ID: 17522248
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects.
Zdravkovic M; Christiansen T; Eliot L; Agersoe H; Thomsen MS; Falch JF; Søgaard B; Ynddal L; Ilondo MM
Growth Horm IGF Res; 2001 Feb; 11(1):41-8. PubMed ID: 11437473
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers.
Zdravkovic M; Søgaard B; Ynddal L; Christiansen T; Agersø H; Thomsen MS; Falch JE; Ilondo MM
Growth Horm IGF Res; 2000 Aug; 10(4):193-8. PubMed ID: 11032702
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
7. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T
Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
[TBL] [Abstract][Full Text] [Related]
10. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
Lee BW; Park SH; Ihm SH; Kim JH; Kim DH; You KC; Kim SW; Yoo HJ
Growth Horm IGF Res; 2008 Aug; 18(4):291-7. PubMed ID: 18178497
[TBL] [Abstract][Full Text] [Related]
11. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
12. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
[TBL] [Abstract][Full Text] [Related]
13. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
14. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans.
Schüssler P; Uhr M; Ising M; Weikel JC; Schmid DA; Held K; Mathias S; Steiger A
Psychoneuroendocrinology; 2006 Sep; 31(8):915-23. PubMed ID: 16814473
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations.
Lucidi P; Murdolo G; Di Loreto C; Parlanti N; De Cicco A; Fatone C; Taglioni C; Fanelli C; Broglio F; Ghigo E; Bolli GB; Santeusanio F; De Feo P
Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):410-7. PubMed ID: 16314227
[TBL] [Abstract][Full Text] [Related]
17. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
Luque RM; Gahete MD; Valentine RJ; Kineman RD
J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin does not regulate the GH response to insulin-induced hypoglycaemia in children but could be involved in the regulation of cortisol secretion.
Huber J; Reiterer EE; Sudi K; Gallistl S; Friedl K; Weinhandl G; Aigner R; Borkenstein MH
Clin Endocrinol (Oxf); 2007 Jan; 66(1):143-7. PubMed ID: 17201814
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans.
Enomoto M; Nagaya N; Uematsu M; Okumura H; Nakagawa E; Ono F; Hosoda H; Oya H; Kojima M; Kanmatsuse K; Kangawa K
Clin Sci (Lond); 2003 Oct; 105(4):431-5. PubMed ID: 12773196
[TBL] [Abstract][Full Text] [Related]
20. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
